Serikov · Experimental biology and medicine (Maywood, N.J.) 2009 · Preclinical in vitro and animal xenograft study · n=?

Human term placenta as a source of hematopoietic cells.

Cited 48 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Preclinical laboratory tissue study and xenograft animal model.

PubMed 19429852 · doi:10.3181/0809-BC-262 · record verified 2026-08-30

What was done

Researchers evaluated human term placental tissue to determine if it contains hematopoietic stem and progenitor cells, established protocols for processing and cryopreserving these cells, and tested their functionality via in vitro colony-forming assays (erythroid and myeloid) and in vivo xenotransplantation into immunodeficient mice.

What was found

Human placental tissue contained large quantities of CD34-expressing hematopoietic cells, providing an estimated cellular yield several-fold greater than typical umbilical cord blood collections. Both fresh and cryopreserved placental cells generated erythroid and myeloid colonies in vitro and reconstituted lymphoid cells following transplantation into immunodeficient mice. The abstract reports no exact numerical values, sample sizes, or statistical metrics.

Why it matters

Umbilical cord blood transplantation is frequently constrained by low total cell doses for adult recipients; identifying the placenta as a rich, cryopreservable source of functional hematopoietic progenitors offers a potential strategy to expand cell yields for allogeneic transplantation.

Limits

This is entirely preclinical bench and animal work; clinical utility, safety, and long-term multilineage reconstitution in human recipients were not evaluated. The abstract omits sample sizes (number of human placentas and mice evaluated), exact cell yields, quantitative comparison metrics, and engraftment efficiency rates.

Cited by